Masatsugu Maeda

Title: Masatsugu Maeda: Innovator in Haemopoietin Receptor Technology

Introduction

Masatsugu Maeda is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of novel haemopoietin receptors. His work has implications for various therapeutic applications, showcasing the potential of his inventions in medical science.

Latest Patents

Masatsugu Maeda holds a patent for a haemopoietin receptor and the genetic sequence encoding it. This invention relates to a novel haemopoietin receptor or its derivatives, which interact with cytokine ligands. This interaction facilitates the proliferation, differentiation, and survival of a wide variety of cells. The receptor and its derivatives, along with the genetic sequences, are valuable for developing agonists, antagonists, therapeutics, and diagnostic reagents based on ligand-receptor interactions.

Career Highlights

Maeda is associated with Zenyth Operations Pty. Ltd., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the biotechnology sector, contributing to innovations that may lead to new medical treatments.

Collaborations

Some of his notable coworkers include Tracy Ann Willson and Nicos Anthony Nicola. Their collaborative efforts enhance the research environment and foster innovation within their projects.

Conclusion

Masatsugu Maeda's contributions to the field of haemopoietin receptor technology highlight his role as an influential inventor. His patent reflects the potential for significant advancements in therapeutic applications, underscoring the importance of his work in the biotechnology industry.